Literature DB >> 20542344

Evaluation of the radiobiological impact of anatomic modifications during radiation therapy for head and neck cancer: can we simply summate the dose?

Jonathan Orban de Xivry1, Pierre Castadot, Guillaume Janssens, John Aldo Lee, Xavier Geets, Vincent Grégoire, Benoît Macq.   

Abstract

BACKGROUND AND
PURPOSE: Adaptive strategies in radiotherapy (RT) require the knowledge of the total dose given to every organ of the body. Because of anatomical changes and setup errors non-rigid registration is necessary to map the different dose fractions to a common reference. This study evaluates practically if the accumulation of all of these registered dose fractions must take radiobiology into account in a classical clinical setting.
MATERIALS AND METHODS: Ten patients with head and neck tumors treated by chemo-RT were used. Contrast-enhanced CT scans were acquired prior and during RT following delivery of mean doses of 14.2, 24.5, 35.0 and 44.9 Gy and the planned pre-treatment helical tomotherapy sinograms were applied on the per-treatment CTs to create a series of per-treatment dose distributions corresponding to each per-treatment CT image. In order to calculate the cumulative dose distribution, the per-treatment dose maps were non-rigidly deformed by using the deformation map computed by a non-rigid registration. The deformed dose maps were then summed in two ways: one while taking radiobiology into account and one without. These two strategies were compared using clinical surrogates in the target volumes (TV) and in surrounding organs at risk (OAR).
RESULTS: The differences between the strategies, while statistically significant (p<0.05), are clinically irrelevant. In the OARs, the mean differences stay in the 0.01-0.07 Gy range for the total dose. In the targets, all mean differences stay in the 0.001-0.012 Gy range. However, some local high difference spots appear leading to punctual errors as high as 2.5 Gy.
CONCLUSION: If using current radiotherapy practices and clinical recommendations based on dose surrogates computed globally on OARs and TVs, one does not need to take radiobiological effects into account while accumulating total dose as these lead to very small differences compared to a simple accumulation technique consisting of a linear sum of the dose fractions. However, care must be taken if other adaptive strategies, based on local rather than global information, are used. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20542344     DOI: 10.1016/j.radonc.2010.05.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Motion-compensated estimation of delivered dose during external beam radiation therapy: implementation in Philips' Pinnacle(3) treatment planning system.

Authors:  Shyam Bharat; Parag Parikh; Camille Noel; Michael Meltsner; Karl Bzdusek; Michael Kaus
Journal:  Med Phys       Date:  2012-01       Impact factor: 4.071

Review 2.  Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?

Authors:  Vincent Grégoire; Robert Jeraj; John Aldo Lee; Brian O'Sullivan
Journal:  Lancet Oncol       Date:  2012-06-28       Impact factor: 41.316

3.  Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.

Authors:  Charles B Simone; David Ly; Tu D Dan; John Ondos; Holly Ning; Arnaud Belard; John O'Connell; Robert W Miller; Nicole L Simone
Journal:  Radiother Oncol       Date:  2011-06-12       Impact factor: 6.280

4.  Methodology for Registration of Shrinkage Tumors in Head-and-Neck CT Studies.

Authors:  Jianhua Wang; Jianrong Dai; Yongjie Jing; Yanan Huo; Tianye Niu
Journal:  Comput Math Methods Med       Date:  2015-05-18       Impact factor: 2.238

5.  A novel setup approach for helical tomotherapy in head and neck cancer: A case report.

Authors:  Marciana Nona Duma; Hans Geinitz; Severin Kampfer; Marco R Kesting
Journal:  Oncol Lett       Date:  2013-09-02       Impact factor: 2.967

6.  Impact of the Intra- and Inter-observer Variability in the Delineation of Parotid Glands on the Dose Calculation During Head and Neck Helical Tomotherapy.

Authors:  T Piotrowski; K Gintowt; A Jodda; A Ryczkowski; W Bandyk; B Ba K; M Adamczyk; M Skorska; J Kazmierska; J Malicki
Journal:  Technol Cancer Res Treat       Date:  2015-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.